Snap8 – 10mg

Snap-8 (chemically known as Acetyl Octapeptide-3) is a synthetic, next-generation neuropeptide consisting of eight linearly arranged amino acids. Engineered as an advanced extension of the classic hexapeptide Argireline (Acetyl Hexapeptide-8), Snap-8 features an additional two-amino-acid sequence (Alanine and Aspartic Acid) that significantly enhances its binding affinity and molecular stability. It is heavily utilized in topically oriented dermal and neuro-signaling research to evaluate the non-invasive inhibition of muscle contractions and the mitigation of dynamic expression lines. [1, 2, 3, 4, 5, 6]

Key Features & Characteristics

• Mechanism of Action: Functions as a structural mimic of the N-terminal domain of the SNAP-25 protein. It competitively binds to the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein Receptor) complex, destabilizing vesicle fusion. [1, 2, 3, 4]
• Neurotransmitter Suppression: By disrupting the SNARE protein architecture, it prevents synaptic vesicles from efficiently docking and releasing acetylcholine into the neuromuscular junction. [1, 2]
• Enhanced Molecular Potency: The elongated octapeptide chain provides a higher baseline binding efficiency at the synaptic interface compared to earlier hexapeptide models. [1, 2]
• Physical Form: Produced via high-fidelity peptide synthesis and supplied as a highly stable, white lyophilized powder requiring precise laboratory reconstitution. [1]

Primary Research Applications

• Dynamic Wrinkle Topography: Widely studied in dermatological and cosmetic science models to observe the depth reduction, smoothing, and relaxation of expression lines (such as crow’s feet and forehead wrinkles) caused by repetitive micro-movements.
• Neuromuscular Signaling Mimicry: Investigated in neurochemical assays as a safer, reversible, and non-paralytic alternative framework to study botulinum neurotoxin-like pathways without cell destruction.
• Topical Formulation & Permeability: Utilized in transdermal delivery research to map out how hydrophilic small-chain peptides can cross lipophilic stratum corneum barriers to target superficial sub-dermal muscle tissue. [1, 2, 3, 4, 5, 6]

For Research Use Only. Not for human consumption, therapeutic, or diagnostic use.